Phathom Pharmaceuticals, Inc. (PHAT) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts PHAT Hot Sheet
Join SI Premium – FREE
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) reported Q1 EPS of ($1.07), $0.04 better than the analyst estimate of ($1.11). Revenue for the quarter came in at $28.5 million versus the consensus estimate of $27.75 million.
For earnings history and earnings-related data on Phathom Pharmaceuticals, Inc. (PHAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades Fidelity National Information Services (FIS) to Market Perform
- Live Wildly and the Trust for Public Land Congratulate Florida Voters for Big Election Wins that Protect Healthy Lands and Waters
- Twilio (TWLO) PT Raised to $320 at Tigress Financial Partners
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
